Kathleen Coll

2.7k citations

37 papers · 2.2k indexed · h-index 24

Impact in

Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
Biochemistry top 5%

Papers in

Toxicology 2
Oncology 11
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 8

Co-authors: John Williamson Elizabeth Murphy T. L. Rich RA Cooper Suresh K. Joseph James S. Marks Andrew P. Thomas Marc E. Tischler
Journals: Journal of Biological Chemistry (13 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)Advances in experimental medicine and biology (2 papers)Vaccine (2 papers)Annals of the New York Academy of Sciences (2 papers)
Partner nations: United States Poland Canada

In The Last Decade

Kathleen Coll

36 papers receiving 2.0k citations

Peers

Countries citing papers authored by Kathleen Coll

Since Specialization

Citations

This map shows the geographic impact of Kathleen Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Coll more than expected).

Fields of papers citing papers by Kathleen Coll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Coll. The network helps show where Kathleen Coll may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kathleen Coll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kathleen Coll Line = papers co-authored together Kathleen Coll links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids Vaccine ·C.G. Kim, Janie Parrino, Rahminah Rahminah, Jabez B. Greenhalgh, Jon E. Stek, Kathleen Coll, Shu‐Chih Su, Jin Xu, Xiaoming Li, Katia Schlienger, Jeffrey L. Silber	2015	26
2	Disputing citizenship Bristol University Press eBooks ·John Clarke, Kathleen Coll, Evelina Dagnino, Catherine Neveu	2014	45
3	Disputing Citizenship Policy Press eBooks ·John Clarke, Kathleen Coll, Evelina Dagnino, Catherine Neveu	2014	11
4	Disputing citizenship Policy Press eBooks ·John Clarke, Kathleen Coll, Evelina Dagnino	2014	23
5	Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster Vaccine ·John Raphael B. Cruz, Stephen K. Tyring, Myron J. Levin, Janie Parrino, Xiaoming Li, Kathleen Coll, Jon E. Stek, Katia Schlienger, Ivan S. F. Chan, Jeffrey L. Silber	2010	51
6	The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase Bioorganic & Medicinal Chemistry Letters ·Mark T. Bilodeau, Risnah Pujawaty, Georgia B. McGaughey, Kathleen Coll, K. Pruchniewicz, William F. Hoffman, Randall W. Hungate, Richard Kendall, Rosemary C. McFall, Keith Rickert, Ruth Z. Rutledge, Kenneth A. Thomas	2004	27
7	Property-Based Design of KDR Kinase Inhibitors Current Medicinal Chemistry ·Mark E. Fraley, William F. Hoffman, Kenneth L. Arrington, Randy W. Hungate, George D. Hartman, Rosemary C. McFall, Kathleen Coll, Keith Rickert, Kenneth A. Thomas, Georgia B. McGaughey	2004	24
8	Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR Bioorganic & Medicinal Chemistry Letters ·Zhicai Wu, Mark E. Fraley, Mark T. Bilodeau, E. Tönges, 杨金娥, Fatou Niasse Dia, George D. Hartman, Kathleen Coll, Keith Rickert, Jennifer M. Shipman, Bin Shi, Laura Sepp‐Lorenzino, Kenneth A. Thomas	2004	36
9	Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR Bioorganic & Medicinal Chemistry Letters ·Mark T. Bilodeau, D.V. Zykov, K. Pruchniewicz, Yard.Doç.Dr.Oya Beklan ÇETİN, Kathleen Coll, William R. Huckle, Randall W. Hungate, Richard Kendall, Rosemary C. McFall, Xianzhi Mao, Ruth Z. Rutledge, Kenneth A. Thomas	2003	13
10	2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Peter J. Manley, Fatou Niasse Dia, Mark T. Bilodeau, Kathleen Coll, George D. Hartman, Rosemary C. McFall, Keith Rickert, Risnah Pujawaty, Kenneth A. Thomas	2003	23
11	Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley, Kenneth L. Arrington, Carolyn A. Buser, Yard.Doç.Dr.Oya Beklan ÇETİN, Kathleen Coll, Christine Fernandes, George D. Hartman, William F. Hoffman, Joseph J. Lynch, Rosemary C. McFall, Keith Rickert, Romi Singh, Sheri Smith, Kenneth A. Thomas, Bradley K. Wong	2003	43
12	Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5-a]pyrimidines: A New Class of KDR Kinase Inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley, William F. Hoffman, Robert S. Rubino, Randall W. Hungate, Andrew J. Tebben, Ruth Z. Rutledge, Rosemary C. McFall, William R. Huckle, Richard Kendall, Kathleen Coll, Kenneth A. Thomas	2002	105
13	Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics Bioorganic & Medicinal Chemistry Letters ·Mark E. Fraley, Robert S. Rubino, William F. Hoffman, Змитриченко Юлия Геннадьевна, Kenneth L. Arrington, Randall W. Hungate, Mark T. Bilodeau, Andrew J. Tebben, Ruth Z. Rutledge, Richard Kendall, Rosemary C. McFall, William R. Huckle, Kathleen Coll, Kenneth A. Thomas	2002	79
14	Nucleotide Mimetics Reverse Phospholamban Regulation in Cardiac Sarcoplasmic Reticulum Annals of the New York Academy of Sciences ·Kathleen Coll, Robert G. Johnson, Edward J. McKenna	1998	2
15	Dissociation of Phospholamban Regulation of Cardiac Sarcoplasmic Reticulum Ca2+ATPase by Quercetin Journal of Biological Chemistry ·Edward J. McKenna, Jeffrey S. Smith, Kathleen Coll, Merve Suna ÖZEL-ÖZCAN, Ernest Mayer, Andreas Rietbrock, Richard T. Wiedmann, Robert G. Johnson	1996	43
16	Formation and Metabolism of Inositol Phosphates: The Inositol Tris/Tetrakisphosphate Pathway Advances in experimental medicine and biology ·John Williamson, Carl A. Hansen, Roy A. Johanson, Kathleen Coll, Small Ds	1988	6
17	Quantitation and early kinetics of inositol lipid changes induced by vasopressin in isolated and cultured hepatocytes. Journal of Biological Chemistry ·Andrew P. Thomas, James S. Marks, Kathleen Coll, John Williamson	1983	192
18	Kinetics of glutamate efflux in rat liver mitochondria. Journal of Biological Chemistry ·Jan B. Hoek, Kathleen Coll, John Williamson	1983	8
19	Hormonal effects on calcium homeostasis in isolated hepatocytes. Journal of Biological Chemistry ·Elizabeth Murphy, Kathleen Coll, T. L. Rich, John Williamson	1980	395
20	Kinetics and regulation of the glutamate-aspartate translocator in rat liver mitochondria. Journal of Biological Chemistry ·Elizabeth Murphy, Kathleen Coll, R. G. Myers, Marc E. Tischler, John Williamson	1979	52

About Kathleen Coll

Kathleen Coll is a scholar working on Toxicology, Oncology, Clinical Biochemistry, Cellular and Molecular Neuroscience and Physiology, having authored 37 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Ion channel regulation and function (9 papers), HER2/EGFR in Cancer Research (8 papers), Mitochondrial Function and Pathology (5 papers), Neuroscience and Neuropharmacology Research (5 papers), Adipose Tissue and Metabolism (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). The work is most often cited by research in Clinical Biochemistry (258 citations), Biochemistry (147 citations), Molecular Biology (1.2k citations), Physiology (419 citations) and Cellular and Molecular Neuroscience (279 citations). Kathleen Coll has collaborated with scholars based in United States, Poland and Canada. Frequent co-authors include John Williamson, Elizabeth Murphy, T. L. Rich, RA Cooper, Suresh K. Joseph, James S. Marks, Andrew P. Thomas, Marc E. Tischler, Elżbieta Wałajtys-Rode and Barbara E. Corkey. Their work appears in journals such as Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters, Advances in experimental medicine and biology, Vaccine and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact